bioAffinity Technologies, Inc.
BIAF- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001712762
No open-market purchases or sales by bioAffinity Technologies, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $782.5K in total; no superinvestor holds it.
Other share classesBIAFW
Q3 2024 vs. Q2 2024
How the institutions holding bioAffinity Technologies, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 17 | 14 | −3 |
| Shares | 399.7K | 467.8K | +68.1K (+17.0%) |
| Value | $863.3K | $973.0K | +$109.7K (+12.7%) |
New holders (2)
Institutions that held bioAffinity Technologies, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 11,264 | $23.4K | 0.00% |
| Clear Street LLC | 100 | $208 | 0.00% |
Sold out (5)
Institutions that held bioAffinity Technologies, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Renaissance Technologies LLC | 22,967 | $49.6K |
| Ground Swell Capital, LLC | 22,864 | $49.4K |
| UBS Group AG | 9,591 | $20.7K |
| Cypress Capital, LLC | 200 | $432 |
| Qube Research & Technologies Ltd | 38 | $82 |